Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro

Clinical trials and studies have shown that combination estrogen/progestin hormone replacement therapy, but not estrogen therapy alone or placebo, increases breast cancer risk in postmenopausal women. Using animal models, we have previously shown that both natural and synthetic progestins (including...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyette, Sandy, Liang, Yayun, Mafuvadze, Benford, Cook, Matthew T, Munir, Moiz, Hyder, Salman M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446973/
https://www.ncbi.nlm.nih.gov/pubmed/28579829
http://dx.doi.org/10.2147/BCTT.S135371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446973/
https://www.ncbi.nlm.nih.gov/pubmed/28579829
http://dx.doi.org/10.2147/BCTT.S135371

Ejemplares similares